Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States

Background: In September 2014, 13-valent pneumococcal conjugate vaccine (PCV13) was universally recommended for all US adults aged ≥65 years. Adult PCV13 coverage, including whether disparities in uptake exist, however, is not well-described. Methods: We used a monthly series of cross-sectional anal...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Main Authors: McLaughlin, John M., Swerdlow, David L., Khan, Farid, Will, Oliver, Curry, Aaron, Snow, Vincenza, Isturiz, Raul E., Jodar, Luis
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605819/
https://ncbi.nlm.nih.gov/pubmed/30676236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1564434
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares